Cardioneuroablation for treatment of carotid sinus syndrome secondary to orofarengeal squamoz cell cancer.
Journal of Cardiovascular Electrophysiology 2023 March 24
INTRODUCTION: Cardioneuroablation may be an alternative to pacing therapy to treat carotid sinus syndrome secondary to inoperable head and neck tumors.
METHODS: We performed, bi-atrial electroanatomic-mapping-guided (a fractionated electrogram-based) cardioneuroablation treatment.
RESULTS: Ablation procedure led to an increase in resting sinus heart rhythm (from 54 to 81 bpm). During the follow-up period of approximately 6 months, neither any bradycardia episodes (sinus bradycardia, sinus pause, AV block, etc.) nor any symptoms were observed in the patient.
CONCLUSION: In this case, we performed successful cardioneuroablation therapy for the first time in a patient with carotid sinus syndrome secondary to oropharyngeal squamous cell carcinoma. This article is protected by copyright. All rights reserved.
METHODS: We performed, bi-atrial electroanatomic-mapping-guided (a fractionated electrogram-based) cardioneuroablation treatment.
RESULTS: Ablation procedure led to an increase in resting sinus heart rhythm (from 54 to 81 bpm). During the follow-up period of approximately 6 months, neither any bradycardia episodes (sinus bradycardia, sinus pause, AV block, etc.) nor any symptoms were observed in the patient.
CONCLUSION: In this case, we performed successful cardioneuroablation therapy for the first time in a patient with carotid sinus syndrome secondary to oropharyngeal squamous cell carcinoma. This article is protected by copyright. All rights reserved.
Full text links
Trending Papers
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app